MRNA's competitive landscape, particularly against Pfizer, and higher forward P/S ratio suggest the stock is overvalued and ...

Over 200 years after the first successful vaccine was created by an English physician, who discovered that inoculation with the cowpox virus protected against smallpox, vaccines remain one of the […] ...

(Haiyun Jiang | The New York Times) Robert F. Kennedy Jr., President Donald Trump’s nominee for secretary of Health and Human ...

Musk might also take aim at NASA’s other contracts to serve his interests. Last year, for example, he attacked Boeing over ...

So far, Musk has taken a sledgehammer to the U.S. Agency for International Development, setting off alarm bells, and is ...

Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a ...

(Reuters) -Moderna said on Friday that the U.S. FDA paused a late-stage trial of its experimental norovirus vaccine after a case of a rare neurological side effect was reported. The trial of the ...

A trial of Moderna’s norovirus vaccine in the U.S. has been put on hold by the FDA over a reported case of neurological disorder. The phase 3 study is evaluating the candidate, dubbed mRNA-1403 ...

Moderna swung to a loss in the last three months of the year after an early launch of its updated Covid-19 vaccine shifted sales out of the fourth quarter.

Moderna shares recovered from an early dip premarket despite the biotech's quarterly loss, as fading demand for its Covid-19 vaccine hurts sales. The company reported a net loss of $1.1 billion ...